This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Xenon Pharmaceuticals Inc.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Conrad Stewart Winters: Innovator in Pharmaceutical Compositions
Introduction
Conrad Stewart Winters is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for therapeutic applications. His work focuses on innovative solutions for treating various medical conditions.
Latest Patents
Winters holds a patent for "Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents." This invention is directed to pharmaceutical compositions for topical administration to a mammal. The compositions comprise a spiro-oxindole compound, which can be an enantiomer, a racemate, or a non-racemic mixture, or a pharmaceutically acceptable salt thereof. These pharmaceutical compositions are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions. He has 1 patent to his name.
Career Highlights
Conrad Stewart Winters is currently associated with Xenon Pharmaceuticals Inc., where he continues to advance his research and development efforts. His work at the company has positioned him as a key player in the pharmaceutical industry, contributing to innovative therapeutic solutions.
Collaborations
Winters collaborates with various professionals in his field, including his coworker Meidong Yang. Their combined expertise enhances the research and development processes at Xenon Pharmaceuticals Inc.
Conclusion
Conrad Stewart Winters exemplifies innovation in the pharmaceutical sector through his groundbreaking work on spiro-oxindole compounds. His contributions are paving the way for new therapeutic options in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
